Clinical Trials · NCT05569772
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes
- Phase
- Phase 3
- Recruitment status
- Recruiting
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Enrollment
- 252
- Start date
- Sep 2023
- Locations
- 13 sites, Belgium
- Primary endpoint
- type 2 diabetes